Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 32.64
(0.02%)
AUD 32.64
(0.02%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.74 Billion NZD | 17.21% |
| 2023 | 1.48 Billion NZD | -2.26% |
| 2022 | 1.52 Billion NZD | -15.08% |
| 2021 | 1.79 Billion NZD | 45.24% |
| 2020 | 1.23 Billion NZD | 19.83% |
| 2019 | 1.02 Billion NZD | 13.47% |
| 2018 | 907.09 Million NZD | 13.84% |
| 2017 | 796.78 Million NZD | 7.86% |
| 2016 | 738.74 Million NZD | 14.71% |
| 2015 | 644.01 Million NZD | 13.26% |
| 2014 | 568.6 Million NZD | 12.1% |
| 2013 | 507.25 Million NZD | 8.68% |
| 2012 | 466.72 Million NZD | -0.2% |
| 2011 | 467.68 Million NZD | -1.49% |
| 2010 | 474.75 Million NZD | -2.22% |
| 2009 | 485.51 Million NZD | 40.34% |
| 2008 | 345.96 Million NZD | -0.94% |
| 2007 | 349.24 Million NZD | 20.62% |
| 2006 | 289.54 Million NZD | 20.08% |
| 2005 | 241.13 Million NZD | 12.23% |
| 2004 | 214.86 Million NZD | 3.09% |
| 2003 | 208.42 Million NZD | -2.27% |
| 2002 | 213.25 Million NZD | 10.58% |
| 2001 | 192.84 Million NZD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 939.1 Million NZD | 0.0% |
| 2024 FY | 1.75 Billion NZD | 18.24% |
| 2024 Q2 | 803.7 Million NZD | 0.0% |
| 2023 FY | 1.48 Billion NZD | -2.26% |
| 2023 Q4 | 890.5 Million NZD | 0.0% |
| 2023 Q2 | 690.6 Million NZD | 0.0% |
| 2022 Q4 | 781.7 Million NZD | 0.0% |
| 2022 Q2 | 900 Million NZD | 0.0% |
| 2022 FY | 1.52 Billion NZD | -15.08% |
| 2021 FY | 1.79 Billion NZD | 45.24% |
| 2021 Q4 | 1.06 Billion NZD | 0.0% |
| 2021 Q2 | 910.2 Million NZD | 0.0% |
| 2020 Q4 | 692.8 Million NZD | 0.0% |
| 2020 Q2 | 570.9 Million NZD | 0.0% |
| 2020 FY | 1.23 Billion NZD | 19.83% |
| 2019 Q4 | 559.1 Million NZD | 0.0% |
| 2019 FY | 1.02 Billion NZD | 13.47% |
| 2019 Q2 | 511.3 Million NZD | 0.0% |
| 2018 Q4 | 522.4 Million NZD | 0.0% |
| 2018 FY | 907.09 Million NZD | 13.84% |
| 2018 Q2 | 458.4 Million NZD | 0.0% |
| 2017 Q4 | 469.2 Million NZD | 0.0% |
| 2017 FY | 796.78 Million NZD | 7.86% |
| 2017 Q2 | 425.2 Million NZD | 0.0% |
| 2016 Q2 | 380.96 Million NZD | 0.0% |
| 2016 FY | 738.74 Million NZD | 14.71% |
| 2016 Q4 | 434.52 Million NZD | 0.0% |
| 2015 FY | 644.01 Million NZD | 13.26% |
| 2015 Q4 | 354.9 Million NZD | 0.0% |
| 2015 Q2 | 317.44 Million NZD | 0.0% |
| 2014 Q3 | 142.15 Million NZD | -53.23% |
| 2014 Q4 | 319.53 Million NZD | 124.78% |
| 2014 Q1 | 126.81 Million NZD | -56.17% |
| 2014 FY | 568.6 Million NZD | 12.1% |
| 2014 Q2 | 303.91 Million NZD | 139.66% |
| 2013 Q1 | 116.68 Million NZD | 0.0% |
| 2013 Q2 | 116.68 Million NZD | 0.0% |
| 2013 Q3 | 126.81 Million NZD | 8.68% |
| 2013 FY | 507.25 Million NZD | 8.68% |
| 2013 Q4 | 289.31 Million NZD | 128.14% |
| 2012 Q4 | 116.68 Million NZD | 0.0% |
| 2012 FY | 466.72 Million NZD | -0.2% |
| 2012 Q3 | 116.68 Million NZD | -0.2% |
| 2012 Q2 | 116.92 Million NZD | 0.0% |
| 2012 Q1 | 116.92 Million NZD | 0.0% |
| 2011 Q4 | 116.92 Million NZD | 0.0% |
| 2011 Q1 | 118.68 Million NZD | 0.0% |
| 2011 Q3 | 116.92 Million NZD | -1.49% |
| 2011 FY | 467.68 Million NZD | -1.49% |
| 2011 Q2 | 118.68 Million NZD | 0.0% |
| 2010 Q4 | 118.68 Million NZD | 0.0% |
| 2010 FY | 474.75 Million NZD | -2.22% |
| 2010 Q1 | 121.37 Million NZD | 0.0% |
| 2010 Q2 | 121.37 Million NZD | 0.0% |
| 2010 Q3 | 118.68 Million NZD | -2.22% |
| 2009 FY | 485.51 Million NZD | 40.34% |
| 2009 Q4 | 121.37 Million NZD | 0.0% |
| 2009 Q2 | 86.49 Million NZD | 0.0% |
| 2009 Q1 | 86.49 Million NZD | 0.0% |
| 2009 Q3 | 121.37 Million NZD | 40.34% |
| 2008 Q2 | 87.31 Million NZD | 0.0% |
| 2008 Q4 | 86.49 Million NZD | 0.0% |
| 2008 Q1 | 87.31 Million NZD | 0.0% |
| 2008 FY | 345.96 Million NZD | -0.94% |
| 2008 Q3 | 86.49 Million NZD | -0.94% |
| 2007 Q4 | 87.31 Million NZD | 0.0% |
| 2007 Q1 | 72.38 Million NZD | 0.0% |
| 2007 Q2 | 72.38 Million NZD | 0.0% |
| 2007 Q3 | 87.31 Million NZD | 20.62% |
| 2007 FY | 349.24 Million NZD | 20.62% |
| 2006 Q1 | 60.28 Million NZD | 0.0% |
| 2006 Q4 | 72.38 Million NZD | 0.0% |
| 2006 FY | 289.54 Million NZD | 20.08% |
| 2006 Q3 | 72.38 Million NZD | 20.08% |
| 2006 Q2 | 60.28 Million NZD | 0.0% |
| 2005 Q3 | 60.28 Million NZD | 12.23% |
| 2005 Q2 | 53.71 Million NZD | 0.0% |
| 2005 Q1 | 53.71 Million NZD | 0.0% |
| 2005 Q4 | 60.28 Million NZD | 0.0% |
| 2005 FY | 241.13 Million NZD | 12.23% |
| 2004 Q1 | 52.1 Million NZD | 0.0% |
| 2004 Q2 | 52.1 Million NZD | 0.0% |
| 2004 Q3 | 53.71 Million NZD | 3.09% |
| 2004 Q4 | 53.71 Million NZD | 0.0% |
| 2004 FY | 214.86 Million NZD | 3.09% |
| 2003 Q1 | 53.58 Million NZD | 0.0% |
| 2003 Q3 | 52.1 Million NZD | -2.77% |
| 2003 FY | 208.42 Million NZD | -2.27% |
| 2003 Q4 | 52.1 Million NZD | 0.0% |
| 2003 Q2 | 53.58 Million NZD | 0.0% |
| 2002 Q1 | 48.21 Million NZD | 0.0% |
| 2002 FY | 213.25 Million NZD | 10.58% |
| 2002 Q4 | 53.58 Million NZD | 0.0% |
| 2002 Q3 | 53.58 Million NZD | 11.15% |
| 2002 Q2 | 48.21 Million NZD | 0.0% |
| 2001 Q3 | 48.21 Million NZD | 0.0% |
| 2001 FY | 192.84 Million NZD | 0.0% |
| 2001 Q4 | 48.21 Million NZD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Austco Healthcare Limited | 58.15 Million AUD | -2896.922% |
| Nanosonics Limited | 171.56 Million AUD | -915.849% |
| Osteopore Limited | 2.21 Million AUD | -78496.236% |
| SDI Limited | 111.2 Million AUD | -1467.182% |
| Trajan Group Holdings Limited | 155.02 Million AUD | -1024.22% |